Transcript Diapositive 1

Ready-to-use syringes:
Do they have the potential to improve the safety
in an intensive care unit and an emergency room?
1,4Stéphanie
Martignoni, 1Thérèse Evard-Sigrist, 1Cyril Stucki,
2Christine Chemin, 3Josette Simon, 1,4Pascal Bonnabry
1Pharmacy, 2Intensive
Care Unit and 3Emergency Department, Geneva University Hospital
4School of pharmaceutical sciences, University of Geneva, University of Lausanne, Geneva, Switzerland
BACKGROUNG AND OBJECTIVES
Numerous powerful intravenous drugs are daily prepared in the intensive care units (ICU) as well as the
emergency room (ER) and most often in a fast-paced and stressful surrounding increasing the risk of errors.
We conducted an observational study in order :
 To obtain a detailed overview of intravenous drugs handling in these wards.
 To gauge the interest of providing ready-to-use syringes to improve the safety of most critical drugs
DESIGN
A standardized grid was developed to gather data on dilutions, asepsis and labeling risk of errors while
preparing drugs.
Interview with the staff were conducted in order to understand their perception of risk regarding drug
handling.
72%
RESULTS

Drug handling: 115 drugs preparations
observed in 13 half-days
anti-infectious

Asepsis: 72% of the time, no aseptic
precaution while preparing drugs
42%
cardio
15
20
6
27%
homeostasis
5
hemesis
21
19%
curare
12%
18
steroides
25

ICU
35%
35%
analgesia-sedation
5
6%
9%
Labeling: 18 drugs out of 115 were not labeled

Hands
Vials
23%
9%
3%
others
80%
ER
Caps
Swaps
Gloves Nothing
Setting for drug handling: Wards versus Pharmacy-CIVAS
60%
51%
25%
29%
3%

4% 1%
t
s
a
a
e
e
e
n
r
t
t
s
s
n
o
i
u
i
a
a
m
e
o
v
t
o
d
d
u
v
d
l
l
a
h
s
r
o
o
'
t
t
s
v
n
n
e
e
c
i
t
n
a
o
p
c
Risk criteria ranked by priorities by the
nurses and “most needed” CIVAS
Emergencies
Complex handling
Risk of confusion
adrenalin
noradrenalin
amiodarone
CONCLUSION
This observational study showed which risks ready-to-use
syringes could tackle:  Error of dilutions
 Lack of correct labeling
FUTURE
 Non-respect of aseptic procedures
Adrenalin, noradrenalin an amiodarone will come first in
our list of CIVAS to be developed to address the specific
needs highlighted in our two-sided study.
ESCP – GSASA Symposium on Clinical Pharmacy
Geneva 2009
This poster can be downloaded and printed at following address: http://pharmacie.hug-ge.ch/rd/posters.html